Depression, Anxiety, and Insomnia among Older COVID-19 Survivors: A Cross-Sectional Study

Objective: The psychological morbidities following coronavirus disease (COVID-19) infection among survivors have been identified as a significant public health challenge since the beginning of the COVID-19 pandemic. Emerging evidence indicates higher prevalence of psychological consequences among elderly COVID-19 survivors. The aim of this study was to explore the psychological morbidities among elderly COV-ID-19 survivors and associated socio-demographic and clinical factors. Methods: A cross-sectional study among older COVID-19 survivors (age >50 years) was conducted in a tertiary care hospital from October 2021 to December 2021. Patients attending medical outpatient department were screened for laboratory-confirmed COVID-19 infection in the past and they were recruited for the study after obtaining written informed consent. The study used a semi-structured proforma and rating scales such as Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and The Insomnia Severity Index (ISI) for depression, anxiety, and insomnia, respectively. Results: The study results indicate that the prevalence of depression, anxiety, and insomnia among 99 older COVID-19 survivors is 35.4%, 31.3%, and 21.2%, respectively. There was statistically significant higher mean of ISI total score (p=0.012) among females. There was statistically significant higher mean PHQ-9 total score among widowed/seperated/divorced group when compared to married group (p=0.006). There was statistically significant higher mean ISI total score (p=0.011) among patients who received oxygen therapy while admitted for COVID-19. There was significantly higher rate of depression among females (p=0.047), widowed/seperated/divorced group (p=0.001), and patients who received oxygen therapy (p=0.004). Conclusion: This study findings implicates that elderly COVID-19 survivors are at significantly higher risk for post-COVID-19 psychological morbidities and should be screened regularly during follow-ups for timely and effective management. Copyright © 2022 Korean Academy of Sleep Medicine

Factors Associated With COVID-19 Vaccination Uptake Among Community-Dwelling Patients With Severe Mental Illness: A Cross-Sectional Study.

Objective: Coronavirus disease 2019 (COVID-19) vaccination uptake among individuals with severe mental illness (SMI) is a public health challenge due to various individual level as well as systemic level barriers. The objective of this study was to explore COVID-19 vaccination status among community-dwelling patients with SMI and identify associated factors.Methods: A cross-sectional study was conducted among patients with SMI attending community psychiatry clinics in Northern Kerala from April 21, 2021, to August 3, 2021, using a structured questionnaire. Sociodemographic information and COVID-19-related information, including vaccination status and agreement with COVID-19 vaccination-related statements, were obtained.Results: Of the 62 respondents, only 27.9% received COVID-19 vaccination. Also, 59.7% of respondents received a recommendation for vaccination from their health care providers. The mean age of the vaccinated group was significantly higher than that of the unvaccinated group (F = 1.3359, P < .001). The rate of vaccination uptake among respondents who were contacted by their health care provider for COVID-19 vaccination was significantly higher (P = .001). Respondents in the vaccinated group perceived the vaccine to be more effective in preventing COVID-19 infection than those in the unvaccinated group (2.06 vs 2.64, P = .031). Also, vaccinated respondents were less in agreement regarding the statement about the risk of COVID-19 vaccine worsening mental illness (4.18 vs 3.67, P = .049). Age and recommendation for vaccination from health care providers were found to be significant predictors of COVID-19 vaccination uptake.Conclusions: On the basis of the study findings, it is recommended that tailored educational activities regarding the safety and efficacy of the COVID-19 vaccine along with recommendation by health care providers can significantly improve COVID-19 vaccination uptake among patients with SMI.

Psychological Morbidity Among COVID-19 Survivors: A Cross-Sectional Study Among Health Care Workers.

Objective: A range of psychiatric morbidities such as persistent depression, anxiety, insomnia, and posttraumatic stress disorder (PTSD) has been observed in coronavirus disease 2019 (COVID-19) survivors. The objective of this study was to explore the psychological status of health care workers after recovery from COVID-19 and to examine the sociodemographic and clinical factors associated with psychiatric morbidity.Methods: A cross-sectional study was conducted among health care workers of a tertiary care hospital in South India. The study included health care workers who tested positive for COVID-19 according to the provisional guidelines of the World Health Organization. The data were collected after they tested negative for COVID-19 from September 2020 to October 2020. The study used a semistructured proforma and rating scales such as the 9-item Patient Health Questionnaire, 7-item Generalized Anxiety Disorder Scale, and Posttraumatic Stress Disorder Checklist for DSM-5 to assess for depression, anxiety, and PTSD.Results: The results indicate that the prevalence of depression, anxiety, and PTSD among 107 post-COVID patients was 26.2%%, 12.1%, and 3.7%%, respectively. Female sex (P = .017), patients with post-COVID persistent physical symptoms (P = .05), and the duration of fever during the acute phase of COVID-19 infection (P = .005) were found to have a statistically significant association with a higher rate of depression among the study population.Conclusions: The study findings indicate that all COVID-19 survivors working in the health care sector should be screened for depression and anxiety disorders regularly for early detection and effective management.

Multisystem inflammatory syndrome with features of incomplete kawasaki disease in an adolescent boy with covid-19

Although the coronavirus disease (COVID-19) in the pediatric population appears to be less severe among children <18 years old, emerging evidence from Europe, North America, Asia, and Latin America indicates that COVID-19 infection may precipitate the hyperinflammatory state among children following infection. This paper reports a case of multisystem inflammatory syndrome with features of incomplete Kawasaki disease in an adolescent boy who also tested positive for COVID-19 antibody. This case highlights the potential COVID-19 complications in adolescents. © 2021 Asociacion Espanola de Dietistas-Nutricionistas. All rights reserved.

Insomnia in covid-19 survivors: A cross sectional study among healthcare workers

Objective: Coronavirus disease (COVID-19) infection predisposes patients to various psychiatric disorders. Study results indicate significantly higher prevalence of insomnia among patients with COVID-19 during active phase. Acute insomnia during active phase of COVID-19 can persist even after recovery, and can transform into chronic insomnia. There are not many studies exploring insomnia among COVID-19 survivors. Our study aims to explore insomnia and its correlation among healthcare workers with confirmed infection of COVID-19 after recovery. Methods: One hundred and seven COVID-19 survivors participated in the study. The social demographic and clinical information of all participants was collected by a structured self report questionnaire. Insomnia was evaluated using the Insomnia Severity Index. Results: The prevalence of insomnia was 21.5% among the healthcare workers with confirmed COVID-19 infection after recovery. There were significant positive correlation between the duration of fever and insomnia severity (0.247, p=0.01). Conclusion: Our study among healthcare workers recovered from COVID-19 provides evidence for high prevalence of insomnia among COVID-19 survivors. The results of this study demands that specific support measures should be planned and implemented to address insomnia among healthcare workers recovered from COVID-19. © 2021 Korean Academy of Sleep Medicine.